Scarica l'app Stockscreener
1.15
1.77%
0.02
Precedente Chiudi:
$1.13
Aprire:
$1.22
Volume 24 ore:
81,635
Relative Volume:
0.19
Capitalizzazione di mercato:
$164.38M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-1.7692
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
-22.30%
1M Prestazione:
-14.18%
6M Prestazione:
-33.14%
1 anno Prestazione:
-41.62%
Intervallo 1D:
$1.14
$1.2253
Intervallo di 1 settimana:
$1.13
$1.5109
Portata 52W:
$1.11
$2.21
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Confronta BDSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
1.15 | 164.38M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
557.16 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
239.97 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
145.75 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.48 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
428.82 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Barclays PLC - Defense World
Preliminary results show sales boost for Biodesix - BizWest
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewswire
Biodesix Achieves Record 45% Revenue Growth to $71.3M as Lung Diagnostics Surges in 2024 - StockTitan
Geode Capital Management LLC Has $1.43 Million Stock Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - The Manila Times
Biodesix's Lung Cancer Blood Test Outperforms PET Scans in Major Clinical Study - StockTitan
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 44.7% - MarketBeat
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Wilmington Savings Fund Society FSB Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Best Project, Interior/Tenant: Biodesix Corporate Headquarters and Laboratory - Engineering News-Record
Insider Buys Additional US$234k In Biodesix Stock - Yahoo Finance
Biodesix director Jack Schuler buys $122,840 in stock By Investing.com - Investing.com Canada
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock By Investing.com - Investing.com Canada
Biodesix director Jack Schuler buys $122,840 in stock - Investing.com
Biodesix Inc director Jack Schuler buys $234,000 in shares - Investing.com India
Biodesix Inc director Jack Schuler buys $234,000 in shares By Investing.com - Investing.com UK
With A 26% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For - Simply Wall St
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - MSN
Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Biodesix chief commercial officer sells shares worth $644 By Investing.com - Investing.com Australia
Biodesix chief commercial officer sells shares worth $644 - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock - Investing.com
Biodesix chief accounting officer sells $283 in stock - Investing.com
Insider Buys Additional US$137k In Biodesix Stock - Simply Wall St
Biodesix chairman John Patience acquires $103,710 in stock - Investing.com India
Biodesix chairman John Patience acquires $103,710 in stock By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys $136k in stock - Investing.com
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock - Investing.com
Biodesix director Matthew Strobeck acquires $55,915 in stock - Investing.com
Biodesix director Massarany buys $30,865 in common stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock By Investing.com - Investing.com Nigeria
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Releases Quarterly Earnings Results, Meets Expectations - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biodesix Inc Azioni (BDSX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kennedy Lawrence T. Jr | Director |
Nov 21 '24 |
Buy |
1.16 |
35,000 |
40,562 |
10,411,024 |
| SCHULER JACK W | Director |
Nov 20 '24 |
Buy |
1.17 |
200,000 |
234,000 |
31,094,935 |
| Vazquez Chris | Chief Accounting Officer |
Nov 11 '24 |
Sale |
1.39 |
105 |
146 |
11,685 |
| Vazquez Chris | Chief Accounting Officer |
Nov 12 '24 |
Sale |
1.40 |
98 |
137 |
11,587 |
| Pestano Gary Anthony | Chief Development Officer |
Nov 11 '24 |
Sale |
1.39 |
220 |
306 |
127,234 |
| Pestano Gary Anthony | Chief Development Officer |
Nov 12 '24 |
Sale |
1.40 |
207 |
290 |
127,027 |
| O'Kane Kieran | Chief Commercial Officer |
Nov 11 '24 |
Sale |
1.39 |
238 |
331 |
97,672 |
| O'Kane Kieran | Chief Commercial Officer |
Nov 12 '24 |
Sale |
1.40 |
224 |
314 |
97,448 |
| Hutton Scott | President & CEO |
Nov 11 '24 |
Sale |
1.39 |
1,927 |
2,680 |
534,792 |
| Hutton Scott | President & CEO |
Nov 12 '24 |
Sale |
1.40 |
1,813 |
2,540 |
532,979 |
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):